Vinati Organics Limited Valuation

VINATIORGA · Chemicals · Current price ₹1,135

Full stock page
DocStoX fair value
₹1,547
medium confidence · 54/100
Current price
₹1,294
Upside to fair value
+19.5%
Estimate range
₹1,392 – ₹1,702
P/E ratio
24.1x
P/B ratio
4.0x
Model it yourself — Earnings Yield Calculator
Opens pre-filled with Vinati Organics Limited's latest numbers.

Is Vinati Organics Limited undervalued?

We estimate the fair value of Vinati Organics Limited at ₹1,547 per share, against a market price of ₹1,294. That puts the share price about +19.5% below our estimate, at medium confidence. This is our view of what the business is worth, not a target price or a forecast of where the share price will go.

How this fair value is calculated

This estimate comes from 2 methods: Normalized earnings (mid-cycle EV/EBITDA) (₹1,410), Fair multiple (P/E) (₹2,381). Each is weighted by how well its inputs held up for this company. The full working, including the assumptions and what data was missing, is set out below.

The range around this estimate

Our estimate for Vinati Organics Limited spans ₹1,392 to ₹1,702. A margin of safety means buying meaningfully below the estimate: the wider the range, the more room the assumptions leave for error.

Valuation multiples

Vinati Organics Limited trades at a P/E of 24.1x and a P/B of 4.0x, with a dividend yield of 0.7%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

How we got this fair value

Every number below is part of the same estimate for Vinati Organics Limited. Nothing here is a target price or a forecast of where the share price will go.

Medium confidence54/100

Workable, with real gaps. Weigh it alongside your own view rather than on its own.

Estimate range ₹1,392 – ₹1,702

Why this method for this business

Normalized earnings and EV/EBITDA are appropriate for a cyclical chemical business, while relative PE provides a sector benchmark.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Normalized earnings (mid-cycle EV/EBITDA)
₹1,41060% weight

Cyclical valued off mid-cycle earnings and a through-cycle EV/EBITDA (§6.6)

Fair multiple (P/E)
₹2,38110% weight
EV / EBITDA(not enough data)

required inputs missing

  • DCF is not suitable for a cyclical commodity business
  • Book value is not relevant for an asset-heavy chemical company

What was missing

  • Lack of forward EPS estimates
  • Limited analyst coverage
  • No clear moat quantification

What drives it

22 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
Revenue (TTM)
2,226.9 ₹ cr

computed

Net debt
-3.8 ₹ cr

computed

Shares outstanding
10,00,00,000

computed

Sector-median P/E
32.72×

peer-median

Peers used
6

peer-median

EPS (TTM)
48.09 ₹/share

computed

Own-history median P/E
44.35×

reconstructed (one feature, dampened — not a cap)

AssumptionA forward input the model chose. Reasonable people can disagree here.
EBITDA margin (cycle median)
27%

computed (≤5y median)

Through-cycle EV/EBITDA
23.44×

own-history (median of 5y)

JudgementOur read of the evidence, not a measurement.
Term: quality
+4.6%

quality 73/100 (high, stable returns) → premium (ROCE deteriorating → premium halved)

Term: growth
+26.0%

durable ~15% CAGR (ROCE 27% > hurdle) → premium

Term: capital_allocation
-5.7%

capital allocation: falling ROCE / weak cash generation → discount

Term: financial_strength
+8.8%

financial strength: effectively debt-free → premium

Term: history
+10.7%

history: market paid +36% vs sector, dampened ×0.3 (one feature, not the anchor)

Term: sector_rerating
+0.0%

sector re-rating: no sector-norm history → not used

Term: rate_regime
+1.2%

rates: risk-free 6.9% below ~7.1% normal → higher multiple

Term: risk
+0.0%

risk: no analyst-dispersion signal available → neutral (lowers confidence, not PE)

DerivedFalls out of the inputs above: a model output, not an independent input.
Mid-cycle EBITDA
601.3 ₹ cr

computed

Enterprise value
14,093.8 ₹ cr

computed

Premium vs sector
+51.3%

fundamentals + macro (not capped at own history)

Fair-multiple confidence
80%

data completeness + term agreement

Fair P/E
49.51×

sector median × ∏(1+term) — Dynamic Fair Multiple

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Vinati Organics Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 14 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

Understand the ratios

More on Vinati Organics Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.